Evidence map›Paper›PMID 33563670›Full record

ArticleBMJ case reports2021

High-dose steroid and heparin: a novel therapy for cerebral vasculitis associated with presumed group A

Brian Alexander Hummel, Julie Blackburn, Anne Pham-Huy, Katherine Muir

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. European journal of case reports in internal medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Brian Alexander HummelDivision of Infectious Diseases, Immunology and Allergy, Department of Pediatrics, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada bhummel@cheo.on.ca.ORCID http://orcid.org/0000-0003-2801-3949
Julie BlackburnDépartement de Microbiologie et Immunologie, University of Montreal Faculty of Medicine, Montreal, Quebec, Canada.
Anne Pham-HuyDivision of Infectious Diseases, Immunology and Allergy, Department of Pediatrics, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
Katherine MuirDivision of Neurology, Department of Pediatrics, University of Ottawa Faculty of Medicine, Ottawa, Ontario, Canada.
University of Ottawa · CAUniversité de Montréal · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cerebral vasculitis is a serious complication of bacterial meningitis that can cause significant morbidity and mortality due to stroke. Currently, there are no treatment guidelines or safety and efficacy studies on the management of cerebral vasculitis in this context. Herein, we report a case of a previously well 11-year-old girl who presented with acute otitis media that progressed to mastoiditis and fulminant meningitis. Group A

Indexed as

Anti-Bacterial AgentsChildDiagnosis, DifferentialDiagnostic ImagingDrug Therapy, CombinationFemaleHeparinHumansMeningitis, BacterialStreptococcal InfectionsStreptococcus pyogenesVasculitis, Central Nervous SystemAnti-Bacterial AgentsHeparininfection (neurology)meningitisneurology (drugs and medicines)stroke

Identifiers

PMID33563670
PMCPMC7875284
OpenAlexW3128285068

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.